TwinStrand Biosciences logo

TwinStrand Biosciences

twinstrandbio.com

TwinStrand Biosciences develops Duplex Sequencing technology that uses error-corrected DNA sequencing to detect ultra-low-frequency genomic variants missed by conventional next-generation sequencing. Its technology supports researchers studying applications such as residual cancer, mutation signatures and genetic toxicology, with the aim of improving human health and accelerating scientific discovery.

Facts

HQ
Seattle, WA, US
Sectors
Biotechnology Research
Type
Corporation Seattle business license
Employees
51–200
Registered name
TwinStrand Biosciences Inc Seattle business license
Stage
Series B
Members see funding amounts.
.

Is this your organization? Claim it

Members see TwinStrand Biosciences's funding rounds, amounts and investors.

People

  • Jesse Salk
    Jesse Salk Co-founder and CEO
  • Ron Andrews Executive, Chief Executive Officer and Director

Online